Brain Aneurysm News and Research

RSS

A brain/cerebral aneurysm (also known as an intracranial or intracerebral aneurysm) is a weak or thin spot on a blood vessel in the brain that balloons out and fills with blood. The bulging aneurysm can put pressure on a nerve or surrounding brain tissue. It may also leak or rupture, spilling blood into the surrounding tissue (called a hemorrhage). Some cerebral aneurysms, particularly those that are very small, do not bleed or cause other problems. Cerebral aneurysms can occur anywhere in the brain, but most are located along a loop of arteries that run between the underside of the brain and the base of the skull.

New research sheds light on brain aneurysm

New research by an international consortium, including a researcher from Lawrence Livermore National Laboratory, may help physicians better understand the chronological development of a brain aneurysm.

30 May 2014

Finnish study: Size of aneurysm does not impact risk of brain aneurysms rupture

Approximately one third of all brain aneurysms rupture during a patient's lifetime, resulting in a brain haemorrhage. A recent Finnish study demonstrates that, unlike what was previously assumed, the size of the aneurysm does not significantly impact the risk of rupture.

23 May 2014

ER physicians discount early signs of strokes among women, minorities, younger people

Analyzing federal health care data, a team of researchers led by a Johns Hopkins specialist concluded that doctors overlook or discount the early signs of potentially disabling strokes in tens of thousands of American each year, a large number of them visitors to emergency rooms complaining of dizziness or headaches.

4 Apr 2014

Doctors overlook early signs of strokes in people each year

4 Apr 2014

UT Southwestern launches telemedicine program to extend stroke care to patients in rural areas

UT Southwestern Medical Center has launched a state-of-the-art telemedicine program that will extend immediate access to UT Southwestern's nationally recognized stroke care during the crucial time period when treatment is needed for a patient of an ischemic stroke, or clot in one of the brain's blood vessels.

1 Apr 2014

Angry outbursts increase heart attack risk

Call it what you will - getting red in the face, hot under the collar, losing your cool, blowing your top - we all experience anger. And while we know that anger is a normal, sometimes even beneficial emotion, we're also aware of the often harmful connection between anger and health. New research from Beth Israel Deaconess Medical shows an even more compelling reason to think about getting anger in check - a nearly fivefold increase in risk for heart attack in the two hours following outbursts of anger.

4 Mar 2014

Scientists receive $4M grant to identify biomarker for secondary injuries associated with brain

In an effort to lower medical costs, identify patients at risk for injury, and speed patient recovery, scientists will attempt to identify a molecular signal that indicates severity of brain-injury during a $4 million, five-year federal grant to Barrow Neurological Institute at St. Joseph's Hospital and Medical Center, Phoenix Children's Hospital and the Translational Genomics Research Institute (TGen).

5 Dec 2013

NIBIB-funded researchers explore better treatment for brain aneurysms

Thirty thousand Americans suffer severe neurological damage or death from brain aneurysms each year and the existing treatments eventually fail in nearly half of patients. Currently, these "bubbles" in the blood vessel are either clamped off, which requires invasive brain surgery, or filled with platinum coils to induce clotting in the aneurysm. Both treatments, although somewhat effective, can have subsequent problems, including inflammation, incomplete healing, and the development of secondary aneurysms adjacent to the initial site. These complications result in approximately 40 percent of patients needing additional treatment to attempt to re-repair the aneurysm.

28 Nov 2013

Penn brain trauma experts provide latest data, guidelines from Neurocritical Care Society Meeting

A team of experts in neurocritical care, engineering, and informatics, with the Perelman School of Medicine at the University of Pennsylvania, have devised a new way to detect

4 Oct 2013

Study: Racial/ethnic differences in inpatient mortality and postacute care following SAH

University of Toronto researchers examined data on patients who had been hospitalized in the United States for subarachnoid hemorrhage (SAH) and found racial/ethnic differences in the rates of inpatient mortality and hospital discharge to institutional care.

11 Sep 2013

Growing brain aneurysms 12 times more likely to burst, says new UCLA study

Brain aneurysms of all sizes—even small ones no larger than a pea—are up to 12 times more likely to rupture if they are growing, according to a new UCLA study.

3 Jul 2013

Cerebral aneurysms are more likely to rupture if they grow in size

Cerebral aneurysms of all sizes-even small ones below seven millimeters-are 12 times more likely to rupture if they are growing in size, according to a new study published online in the journal Radiology.

2 Jul 2013

Edge Therapeutics announces positive preliminary results from EG-1962 study for prevention of DCI

Edge Therapeutics announced today positive preliminary results from the first human use of EG-1962, the Company's novel bioabsorbable nimodipine microparticle formulation for the prevention of delayed cerebral ischemia, a life-threatening complication of subarachnoid hemorrhage, typically resulting from a ruptured brain aneurysm or traumatic brain injury.

27 Jun 2013

Final results of PUFs clinical study of Covidien's Pipeline device published in June issue of Radiology

Covidien, a leading global provider of healthcare products, today announced that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline embolization device have been published in the June issue of Radiology.

17 Jun 2013

Edge Therapeutics announces FDA acceptance of IND application for EG-1962

Edge Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing life-saving hospital products for acute, fatal or debilitating conditions, announced today that the U.S. Food and Drug Administration has accepted the Company's Investigational New Drug application for EG-1962, a novel bio-absorbable nimodipine microparticle formulation.

10 Jun 2013

UCLA team uses brain aneurysm treatment technique to treat irregular heart rhythms

For the first time, a UCLA team has used a technique normally employed in treating brain aneurysms to treat severe, life-threatening irregular heart rhythms in two patients.

15 Mar 2013

Study questions high rate of cesarean deliveries in women with aneurysms

For women with aneurysms involving the brain blood vessels, pregnancy and delivery don't appear to increase the risk of aneurysm rupture, reports a paper in the February issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

11 Feb 2013

Pipeline embolization device safe and effective tool for patients with brain aneurysms

A multi-center study supports the effectiveness of the newest technology available for the treatment of difficult, life-threatening brain aneurysms. The technology, the Pipeline embolization device, is a flow diverter that redirects blood flow away from wide-necked or giant aneurysms that cannot be treated in more conventional ways.

31 Jan 2013

Viewpoints: Papa John's complaint; Renewed criticism of Justice Roberts; Calif. voters rout food police

If ObamaCare negatively impacts your business, you better not complain about it. That's what Papa John's CEO John Schnatter found out when he announced the health-care law would increase the price of a pizza by up to 14 cents. ... But Papa John's isn't the only restaurant chain to complain that the Affordable Care Act is bad for business.

21 Nov 2012

New neuroprotective agent for stroke patients potentially found

Scientists have shown that a drug called NA-1 results in fewer brain lesions in patients who have undergone surgery to repair a brain aneurysm, compared to placebo, and appears to be safe to use, according to an Article published Online First in The Lancet Neurology.

8 Oct 2012